Through quantitative detection of misfolded proteins by spectrophotometer in pregnant women's urine, to improve the early detection rate of preeclampsia and predict the incidence of preeclampsia in advance.

pre-eclampsia vue™

CercaTest® Pre-Eclampsia Vue™ is a new version of a well documented technique to detect misfolded proteins in the urine of pregnant mothers. In multiple studies this is shown to be an indicator of poor pregnancy outcomes.